Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 8 studies | 31% ± 12% | |
capillary endothelial cell | 8 studies | 25% ± 7% | |
vein endothelial cell | 8 studies | 24% ± 10% | |
endothelial cell of vascular tree | 7 studies | 22% ± 7% | |
epithelial cell | 6 studies | 25% ± 9% | |
classical monocyte | 4 studies | 23% ± 5% | |
myeloid cell | 4 studies | 21% ± 5% | |
glomerular endothelial cell | 3 studies | 26% ± 1% | |
endothelial cell of artery | 3 studies | 26% ± 9% | |
basal cell | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 19% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1594.51 | 1445 / 1445 | 100% | 40.05 | 183 / 183 |
intestine | 100% | 1565.77 | 966 / 966 | 100% | 34.69 | 527 / 527 |
pancreas | 100% | 1352.12 | 328 / 328 | 100% | 25.15 | 178 / 178 |
stomach | 100% | 1484.78 | 359 / 359 | 100% | 33.87 | 286 / 286 |
uterus | 100% | 1494.54 | 170 / 170 | 100% | 25.77 | 459 / 459 |
prostate | 100% | 1353.87 | 245 / 245 | 100% | 18.82 | 501 / 502 |
bladder | 100% | 1541.00 | 21 / 21 | 100% | 28.93 | 502 / 504 |
breast | 100% | 1912.14 | 459 / 459 | 99% | 26.22 | 1110 / 1118 |
lung | 100% | 3390.90 | 578 / 578 | 99% | 22.33 | 1144 / 1155 |
ovary | 99% | 1061.37 | 178 / 180 | 100% | 24.25 | 428 / 430 |
thymus | 100% | 1394.21 | 652 / 653 | 98% | 13.66 | 594 / 605 |
skin | 98% | 958.36 | 1767 / 1809 | 100% | 61.19 | 472 / 472 |
adrenal gland | 100% | 2000.68 | 258 / 258 | 93% | 15.64 | 215 / 230 |
kidney | 100% | 1490.61 | 89 / 89 | 91% | 15.10 | 823 / 901 |
brain | 99% | 1752.01 | 2624 / 2642 | 87% | 8.32 | 614 / 705 |
liver | 99% | 784.72 | 224 / 226 | 71% | 8.50 | 289 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 23.29 | 29 / 29 |
spleen | 100% | 2835.07 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.14 | 1 / 1 |
adipose | 100% | 2469.74 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 1124.69 | 854 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1168.49 | 1322 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 25.85 | 79 / 80 |
tonsil | 0% | 0 | 0 / 0 | 98% | 17.42 | 44 / 45 |
peripheral blood | 76% | 984.16 | 704 / 929 | 0% | 0 | 0 / 0 |
muscle | 36% | 164.47 | 293 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001725 | Cellular component | stress fiber |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | TLNRD1 |
Protein name | Talin rod domain-containing protein 1 (Mesoderm development candidate 1) |
Synonyms | MESDC1 |
Description | FUNCTION: Actin-binding protein which may have an oncogenic function and regulates cell proliferation, migration and invasion in cancer cells. . |
Accessions | ENST00000267984.4 Q9H1K6 |